By Robert M. Carey
Hypertension and Hormone Mechanisms studies novel advancements within the endocrinology of high blood pressure with emphasis on new discovery up to now 5 years and views at the destiny. Written by means of authors who've spearheaded contemporary advances, chapters hide concepts in our realizing of the reninangiotensin-aldosterone, the sympathoadrenal, and the renal dopaminergic platforms. World-renowed researchers additionally speak about natriuretic peptides, vasoactive ingredients and vasopeptidases, insulin, loose fatty acids, and the insulin resistance syndrome, intercourse hormones, and the vasculature and chosen components of prognosis and therapy.
With a spotlight on new advancements in hormones and autacoids concerning high blood pressure, high blood pressure and Hormone Mechanisms presents a source that may bring about new, energetic learn within the primary mechanisms of hypertension.
Read or Download Hypertension and Hormone Mechanisms PDF
Similar endocrinology & metabolism books
"Endocrinology and Metabolism" is a well-liked source protecting uncomplicated rules and scientific administration of all-important endocrine and metabolic ailments. the focal point of this version has been at the id and elucidation of the most recent scientific findings in admire to the analysis and administration of endocrine illness.
Redux™ is a progressive new anti-obesity drug that has simply been authorized (July 1996) through the FDA. it's the first weight administration drug remedy to be introduced within the usa in twenty years and isn't addictive, in contrast to past medicines used for this objective. weight problems administration and Redux™ features a short creation which leads as much as its discovery and comprises an summary of recent tendencies in weight problems administration.
New concepts in diabetes and its treatment
Diabetes mellitus and its problems are stipulations of transforming into significance from either the medical and epidemiological perspective. Diabetes has life-threatening issues affecting a number of organs and platforms, with elevated possibility for ocular, renal, cardiac, cerebral, fearful and peripheral vascular illness.
Actual job and weight problems, moment variation, addresses an array of issues that discover and reveal the hyperlinks among actual task (or state of being inactive) and weight problems. top scientists from a number of backgrounds crew as much as offer an unequalled source studying the most recent learn and advancements within the box.
Additional resources for Hypertension and Hormone Mechanisms
Sample text
Clin. Investig. 109, 1417–1427. 42. , and Sraer, J. D. (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50, 1897–1903. 43. Sealey, J. , Catanzaro, D. , Lavin, T. , et al. (1996) Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site. Am. J. Hypertens. 9, 491–502. 44. Danser, A. H. J. and Saris, J. J. (2002) Prorenin uptake in the heart: a prerequisite for local angiotensin generation?
Cardiol. 34, 1463–1472. 45. Gomez, R. , Lynch, K. , Chevalier, R. , et al. (1988) Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am. J. Physiol. Renal. Physiol. 254, F900–F906. 46. , et al. (1984) Coexistence of renin and angiotensin II in epitheloid cell secretory granules of rat kidney. Histochemistry 81, 39–45. 47. Tank, J. , Henrich, W. , and Moe, O. W. (1997) Regulation of glomerular and proximal tubule renin mRNA by chronic changes in dietary NaCl.
1999) Angiotensin-converting enzyme in non-neoplastic kidney diseases. Kidney Int. 56, 1442–1454. 57. Danser, A. , Admiraal, P. J. , Derkx, F. , and Schalekamp, M. A. (1988) Angiotensin I-to-II conversion in the human renal vascular bed. J. Hypertens. 16, 2051–2056. 58. Admiraal, P. J. , Derkx, F. H. , Danser, A. H. , and Schalekamp, M. A. D. H. (1990) Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis. Hypertension 16, 555–563. 59. , Rinder, D. , Khosla, M. , Navar, L.
